Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$901K Buy
552,596
+121,961
+28% +$166K ﹤0.01% 3809
2026
Q1
$504K Buy
430,635
+86,761
+25% +$138K ﹤0.01% 3859
2025
Q4
$798K Buy
343,874
+240,711
+233% +$598K ﹤0.01% 3676
2025
Q3
$281K Buy
+103,163
New +$297K ﹤0.01% 4145
2024
Q1
Sell
-12,785
Closed -$25.7K 4813
2023
Q4
$25.7K Buy
12,785
+1,630
+15% +$3.27K ﹤0.01% 4053
2023
Q3
$24.8K Buy
+11,155
New +$32.8K ﹤0.01% 3970
2022
Q1
Sell
-11,438
Closed -$81K 6006
2021
Q4
$81K Sell
11,438
-43,668
-79% -$426K ﹤0.01% 5111
2021
Q3
$634K Buy
+55,106
New +$731K ﹤0.01% 3934

Other funds holding ZVIA

David Shaw's ZVIA Position: Q2 2026 in Review

David Shaw increased its Zevia (ZVIA) stake by 28% in Q2 2026, buying an estimated $166K and bringing the position to 552,596 shares worth $901K. The position accounts for ﹤0.01% of the portfolio, ranked #3809.

David Shaw first reported a position in ZVIA in Q3 2021 and has held it in 8 quarters since. 102 funds tracked by Wall St. Rank hold ZVIA as of Q2 2026.

  • David Shaw held 552,596 shares of Zevia worth $901K as of Q2 2026.
  • David Shaw bought 121,961 Zevia shares in Q2 2026, an estimated $166K.
  • Zevia made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3809 holding.
  • David Shaw first reported a position in Zevia in Q3 2021 and has held it in 8 quarters since.
  • 102 funds tracked by Wall St. Rank held Zevia as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.